Alexion Pharmaceuticals (ALXN) PT Raised to $162 at Raymond James
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Raymond James analyst Steven Seedhouse raised the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $162.00 (from $161.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- Semiconductor Manufacturing International Corp. (981:HK) (SMI) PT Raised to HK$153 at Goldman Sachs
- Nyxoah SA (NYXH) PT Lowered to $6 at Cantor Fitzgerald to Reflect Current Trading Levels
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
